What is PBLA stock price today?

Visit our real-time dashboard for the current PBLA stock price and live market data.

Is PBLA stock going up or down today?

PBLA stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy PBLA stock now?

The decision to buy PBLA depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is PBLA a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for PBLA based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is PBLA stock overvalued or undervalued?

Use our DCF valuation calculator to determine if PBLA is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is PBLA's P/E ratio?

P/E ratio data for PBLA will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is PBLA's market cap?

PBLA (Panbela Therapeutics Inc) has a market capitalization of $0.00 billion, making it a small-cap stock.

What is PBLA's price to book ratio?

Price-to-book ratio for PBLA is available on our dashboard along with other valuation metrics.

Does PBLA pay dividends?

PBLA does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is PBLA's dividend yield?

PBLA does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is PBLA stock a good long-term investment?

PBLA's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is PBLA's revenue growth rate?

Revenue growth data for PBLA is available on our dashboard with detailed financial statement analysis.

Profitability metrics for PBLA are available on our dashboard with complete income statement analysis.

What are the risks of investing in PBLA?

Key risks for PBLA include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does PBLA compare to its competitors?

Compare PBLA to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize PBLA's performance and positioning.

What is PBLA's stock price target for 2026?

Visit our prediction page for AI-powered price targets for PBLA with bull, base, and bear case scenarios.

What do analysts say about PBLA?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for PBLA. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is PBLA's next earnings report?

PBLA reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

PBLA - Panbela Therapeutics Inc

NYSE * Healthcare * Biotechnology

$0.00

+$0.00 (+0.00%)

About Panbela Therapeutics Inc

Panbela Therapeutics Inc (PBLA) common stock

Price Chart

Loading chart...

PBLA Key Statistics

Market Cap

$1.02M

How PBLA Compares to Peers

PBLA is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
PBLA(This stock)	$1.02M	N/A	0%	0.0%	-
AMGNAmgen Inc	$188.67B	24.3	0%	0.0%	vs AMGN
GILDGilead Sciences	$160.15B	17.5	0%	0.0%	vs GILD
VRTXVertex Pharmaceuticals	$106.87B	29.7	0%	0.0%	vs VRTX
REGNRegeneron Pharmaceuticals	$59.10B	13.9	0%	0.0%	vs REGN
BIIBBiogen Inc	$29.33B	21.4	0%	0.0%	vs BIIB

Data Updated: July 18, 2026 at 11:10 PM EDT

Ready to invest in PBLA?

Commission-free trading available. Affiliate links.

Upcoming Events for PBLA

Dashboard

Enter a ticker to analyze